Private Advisor Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Private Advisor Group's BIIB Position: Q2 2026 in Review
Private Advisor Group reduced its Biogen (BIIB) stake by 46% in Q2 2026, selling an estimated $409K and leaving 2,510 shares worth $542K. The position accounts for ﹤0.01% of the portfolio, ranked #1743.
Private Advisor Group first reported a position in BIIB in Q4 2013 and has held it in 51 quarters since. The position peaked at $12M in Q3 2021. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Private Advisor Group held 2,510 shares of Biogen worth $542K as of Q2 2026.
- Private Advisor Group sold 2,139 Biogen shares in Q2 2026, an estimated $409K.
- Biogen made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1743 holding.
- Private Advisor Group first reported a position in Biogen in Q4 2013 and has held it in 51 quarters since.
- Private Advisor Group's Biogen position peaked at $12M in Q3 2021.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.